JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $100
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus maintains an Overweight rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $95 to $100.
July 27, 2023 | 1:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JP Morgan maintains an Overweight rating on Edwards Lifesciences and raises the price target from $95 to $100. This could potentially lead to an increase in the stock's price.
The raised price target by JP Morgan indicates a positive outlook for Edwards Lifesciences. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100